Patiromer Enables The Initiation Of Mineralocorticoid Receptor Antagonists (MRAs) For Heart Failure With Reduced Ejection Fraction (HFrEF) In Patients With Hyperkalemia (HK) Or Previous HK: Post HocAnalysis Of The DIAMOND Trial
Year: 2024
Type: article
Source: Journal of Cardiac Failure
Institutions: University of Michigan, Michigan Medicine, University of Warwick, Karolinska University Hospital, National and Kapodistrian University of Athens, Université de Lorraine, University of Maryland, Baltimore, University of Maryland Medical Center, Vifor Pharma (Switzerland), Vifor Pharma (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4391493299
